They also reported a 10-fold higher TLR2 expression in the invasive MDA-MB-231 human triple-negative breast cancer cells compared to the poorly invasive ER+ MCF-7 cells [38]. The gene discussed is TLR2; the disease is triple-negative breast carcinoma.